QSI
Quantum-Si incorporated1.2200
-0.0100-0.81%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
FY Q4 '25
Key Stats
Market Cap
262.90MP/E (TTM)
-Basic EPS (TTM)
-0.67Dividend Yield
0%Recent Filings
8-K
10-K
8-K
8-K
Proteus platform unveiled
Quantum-Si hosted its Investor & Analyst Day on November 19, 2025, unveiling Proteus, a next-gen benchtop platform with 80M wells, full workflow automation, and superior sequencing output over Platinum—more alignments, deeper reads, better SNR. Proteus de-risks key tech, targets YE2026 launch with 18 amino acids at debut, scaling to all 20 by 2027 via AI-driven recognizers. Roadmap eyes billions of reads. Execution on track.
8-K
Q3 revenue $552K; Proteus milestone.
Quantum-Si reported Q3 2025 revenue of $552,000, down from $787,000 last year, with gross margin at 35% amid commercialization ramp. Net loss widened to $35.7 million, hit by $15.4 million in one-time litigation and lease charges, yet cash stands at $230.5 million into Q2 2028. Proteus prototype sequenced successfully; launch on track for H2 2026.
BRKR
Bruker Corporation
44.96-0.71
DGX
Quest Diagnostics Incorporated
178.66-5.45
LAB
Standard BioTools Inc.
1.49-0.02
NOVT
Novanta Inc.
121.36+1.95
PACB
Pacific Biosciences of Californ
2.02-0.10
QDEL
QuidelOrtho Corporation
28.88-0.18
QGEN
Qiagen N.V.
45.01-0.43
QTIH
QT Imaging Holdings, Inc.
6.10-0.02
QTRX
Quanterix Corporation
7.36-0.05
QTZM
Quantumzyme Corp.
3.18+0.02